Retatrutide + Cagrilintide Blend
Quad-pathway metabolic optimisation
Weight Losssubcutaneousany
Overview
Combination of triple-agonist retatrutide with cagrilintide for maximum weight loss potential. Targets GLP-1, GIP, glucagon, and amylin pathways.
Dosing
- Typical Dosage
- 5+5 mg
- Frequency
- Weekly
- Cycle Duration
- Ongoing
- Administration
- subcutaneous
Available Vial Sizes
5mg/5mg10mg/10mg
Experimental combination. Start low and titrate carefully.
Comprehensive Information
AI-GeneratedGenerating comprehensive analysis...
This may take a moment
Mechanism of Action
Key Benefits
Optimal Timing
Potential Side Effects
Stacking Suggestions
Practical Tips
Could not load AI-generated information
Track Your Retatrutide + Cagrilintide Blend Protocol
Join UpgradeYourself to track your peptide protocols, log injections with our interactive body map, and receive AI-powered insights tailored to your health goals.
Free forever planNo credit card required100+ peptides tracked